Actively Recruiting
Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-11-26
40
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
U
University of Bern
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with cancer. Through the use of the Mio-App, cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase. The Mio-App for children and adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the App will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the presence of fatigue. This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of children and adolescents with cancer in the long-term.
CONDITIONS
Official Title
Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent from participant and/or parent/legal guardian
- Age between 8 and 16 years
- Diagnosis of cancer, with or without central nervous system involvement
- Cancer treatment including radiation, chemotherapy, and/or surgical tumor removal
- Participant is between 3 months before to 10 years after completion of cancer treatment
- German or French speaking
You will not qualify if you...
- Any unstable neurological condition such as epilepsy
- Severe psychiatric disease (e.g., eating disorder) or severe learning disability
- Known or suspected non-compliance with study procedures
- Drug or alcohol abuse
- Inability to follow study procedures due to language problems
- Investigator, family members, employees or other dependent persons enrolled in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Insespital, University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
R
Regula Everts, Prof. Dr. phil.
CONTACT
S
Saskia Salzmann, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here